December 9, 2020 | HealthClot

Monoclonal antibodies for multiple myeloma

By HealthClot Moderator
December 9, 2020
0

Monoclonal antibodies for multiple myeloma The continued evolution and refinement of strategies for disease diagnosis, risk assessment, therapeutic intervention and disease management have provided patients with hematologic malignancies and benign hematologic disorders with enhanced outcomes and improved quality of life. The 2016 Great Debates & Updates in Hematologic Malignancies conference, held April 1-2 in New […]

Covid-19 has had ‘devastating effect’ on cancer services

By HealthClot Moderator
December 9, 2020
0

Covid-19 has had ‘devastating effect’ on cancer services The performance of some cancer services is getting worse, not better, due to historical underfunding, a lack of capacity in the system and an under resourced and incomplete workforce, the Irish Cancer Society has said. In an opening statement to the Oireachtas committee on health, the society […]

Cancer Imaging Systems Market To Reach USD 12.24 Billion by 2027 | Emergen Research

By HealthClot Moderator
December 9, 2020
0

Cancer Imaging Systems Market To Reach USD 12.24 Billion by 2027 | Emergen Research Vancouver, British Columbia, Dec. 09, 2020 (GLOBE NEWSWIRE) — The Global Cancer Imaging Systems Market is estimated to garner a valuation of USD 12.24 Billion by the year 2027, as per the latest report by Emergen Research. The cancer imaging systems […]

MRI screening beneficial for women with personal breast cancer history: Study

By HealthClot Moderator
December 9, 2020
0

MRI screening beneficial for women with personal breast cancer history: Study MRI screening beneficial for women with personal breast cancer history: Study Top We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and […]

(Selinexor) Data in Multiple Myeloma and Diffuse Large-B-Cell Lymphoma at the American Society …

By HealthClot Moderator
December 9, 2020
0

(Selinexor) Data in Multiple Myeloma and Diffuse Large-B-Cell Lymphoma at the American Society … Karyopharm Presents XPOVIO® (Selinexor) Data in Multiple Myeloma and Diffuse Large-B-Cell Lymphoma at the American Society of Hematology 2020 Annual Meeting — Pomalyst®, Kyprolis® and Revlimid® Arms of the Phase 1b/2 STOMP Study Evaluating Once Weekly XPOVIO with Low-Dose Dexamethasone Combinations […]